- Home
- STEC vs DYAI Comparison
STEC vs DYAI Comparison
Compare STEC & DYAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STEC
- DYAI
- Stock Information
- Founded
- STEC 2006
- DYAI 1979
- Country
- STEC Hong Kong
- DYAI United States
- Employees
- STEC N/A
- DYAI N/A
- Industry
- STEC
- DYAI Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- STEC
- DYAI Health Care
- Exchange
- STEC NYSE
- DYAI Nasdaq
- Market Cap
- STEC 63.8M
- DYAI 28.3M
- IPO Year
- STEC 2021
- DYAI 2004
- Fundamental
- Price
- STEC $0.74
- DYAI $1.13
- Analyst Decision
- STEC
- DYAI Strong Buy
- Analyst Count
- STEC 0
- DYAI 1
- Target Price
- STEC N/A
- DYAI $6.00
- AVG Volume (30 Days)
- STEC 10.9K
- DYAI 203.9K
- Earning Date
- STEC 08-05-2025
- DYAI 08-12-2025
- Dividend Yield
- STEC N/A
- DYAI N/A
- EPS Growth
- STEC N/A
- DYAI N/A
- EPS
- STEC N/A
- DYAI N/A
- Revenue
- STEC $10,672,000.00
- DYAI $3,554,344.00
- Revenue This Year
- STEC $9,392.20
- DYAI $22.56
- Revenue Next Year
- STEC N/A
- DYAI $30.95
- P/E Ratio
- STEC N/A
- DYAI N/A
- Revenue Growth
- STEC N/A
- DYAI 57.59
- 52 Week Low
- STEC $0.20
- DYAI $0.91
- 52 Week High
- STEC $3.25
- DYAI $2.20
- Technical
- Relative Strength Index (RSI)
- STEC 40.44
- DYAI 62.78
- Support Level
- STEC $0.70
- DYAI $1.08
- Resistance Level
- STEC $0.80
- DYAI $1.20
- Average True Range (ATR)
- STEC 0.08
- DYAI 0.08
- MACD
- STEC 0.00
- DYAI 0.02
- Stochastic Oscillator
- STEC 38.55
- DYAI 50.00
About STEC SANTECH HOLDINGS LIMITED
Santech Holdings Ltd is a technology company focusing on exploring various opportunities in consumer technology, consumer healthcare and enterprise technology. It has two revenue segments Wealth management service and Asset management service. Key revenue is generated from Wealth management service.
About DYAI Dyadic International Inc.
Dyadic International Inc is a worldwide biotechnology platform company. It has developed a gene expression platform for producing commercial quantities of industrial enzymes and other proteins and has licensed this technology to third parties, such as Abengoa Bioenergy, BASF, Codexis and others, for use in industrial (non-pharmaceutical) applications. This technology is based on the Thermothelomyces heterothallica fungus, which the company named C1.